Credit: koto_feja /E+/ Getty Images By stimulating cancer cells to produce and release an enzyme that activates the cGAS-STING signaling pathway in nearby immune cells, MIT researchers found a way…
In a groundbreaking study published in the Journal of Cancer Research and Clinical Oncology, researchers led by J. Taugner and collaborators have uncovered crucial insights into the complex interactions between…
Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at…
In a significant stride for precision oncology, recent research has unveiled promising results for the use of belzutifan in managing Von Hippel-Lindau (VHL) disease-associated tumors. VHL disease is a hereditary…
Credit: Steve Gschmeissner/Science Photo Library Cancer immunotherapies, such as immune checkpoint inhibitors (ICIs), are effective against many types of cancer. However, these treatments don’t work well for some tumors, including…
CAR T-cells attack cancer cell, 3D illustration. Scientists at École Polytechnique Fédérale Lausanne (EPFL), and at UNIL-CHUV, University Hospital Lausanne (CHUV) and University of Lausanne (UNIL) have developed a computational…
A groundbreaking study published in the American Journal of Public Health has unveiled a significant link between air pollution and an increased risk of breast cancer among women in the…
View eBook Across biomedical research and drug development, the boundaries of possibility are shifting. Scientists are uncovering new disease mechanisms, redefining diagnostic strategies, and designing next-generation therapies that demand unprecedented…
Intrahepatic cholangiocarcinoma (iCCA) has garnered increasing attention within the medical community as a unique and challenging subtype of liver cancer. This malignancy, which originates in the bile ducts located within…
Panelists: Jon Stokes, PhD Co-founder and CSO of Stoked BioAssistant Professor at McMaster University Panelist Jon Stokes, PhD Jon Stokes, PhD, is the co-founder and CSO of Stoked Bio and…